U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059611) titled 'Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma' on July 08.
Brief Summary: The research study is being conducted to study whether performing injections of a new treatment, called RP2, directly into stomach and esophagus tumors along with standard chemotherapy (called FLOT) is safe and whether it does a better job of killing cancer before surgery compared to chemotherapy alone.
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Gastric Adenocarcinoma
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Intervention:
BIOLOGICAL: RP2
Upper endoscopy with RP2 intra-tumoral in...